Armistice Capital
NEW YORK, NYfiles as ARMISTICE CAPITAL, LLC
$3.6bn in 323 US stocks at the end of 30 June 2026. The top 10 are 27.4% of the money. It changed about 22.4% of the portfolio this quarter.
Value
$3.6bn
Stocks
323
Top 10 share
27.4%
Turnover
22.4%
What changed this quarter
New
Bought for the first time this quarter.
- WatersWAT0.8% of the fund
- IlluminaILMN0.4% of the fund
- Prestige Consumer HealthcarePBH0.4% of the fund
- Liberty MediaFWONK0.4% of the fund
- Integer HoldingsITGR0.4% of the fund
- Live Nation EntertainmentLYV0.4% of the fund
- Novo Nordisk A SNVO0.4% of the fund
- Twist BioscienceTWST0.4% of the fund
- Take TWO Interactive SoftwareTTWO0.3% of the fund
- Marvell TechnologyMRVL0.3% of the fund
- Boston ScientificBSX0.3% of the fund
- NokiaNOK0.3% of the fund
- NetskopeNTSK0.3% of the fund
- FoxFOXA0.3% of the fund
- Shake ShackSHAK0.3% of the fund
- AramarkARMK0.2% of the fund
- StarbucksSBUX0.2% of the fund
- Spdr Series TrustXRT0.2% of the fund
- AppianAPPN0.2% of the fund
- Rapid Micro BiosystemsRPID0.2% of the fund
- RTB DigitalRTB0.1% of the fund
- LivaNovaLIVN0.1% of the fund
- BrightSpring Health ServicesBTSG0.1% of the fund
- MckessonMCK0.1% of the fund
- CorMedixCRMD0.1% of the fund
Added
Bought more of a stock they already held.
- Madrigal PharmaceuticalsMDGL4.3% of the fund+9%
- Supernus PharmaceuticalsSUPN3.4% of the fund+40%
- CytokineticsCYTK2.8% of the fund+57%
- IncyteINCY2.8% of the fund+37%
- UnitedHealth GroupUNH2.1% of the fund+24%
- FreshpetFRPT2.1% of the fund+15%
- Amazon.comAMZN1.9% of the fund+9%
- Rigel PharmaceuticalsRIGL1.8% of the fund+31%
- Thermo Fisher ScientificTMO1.7% of the fund+34%
- Regeneron PharmaceuticalsREGN1.5% of the fund+149%
- Nektar TherapeuticsNKTR1.4% of the fund+25%
- Mineralys TherapeuticsMLYS1.3% of the fund+48%
- Sanofi SASNY1.3% of the fund+255%
- Immunocore HldgsIMCR1.3% of the fund+20%
- AlphabetGOOGL1.3% of the fund+7%
- Solid BiosciencesSLDB1.2% of the fund+34%
- MongoDBMDB1.2% of the fund+17%
- Dentsply SironaXRAY1.1% of the fund+22%
- GitlabGTLB0.9% of the fund+4%
- HubspotHUBS0.9% of the fund+38%
- Align TechnologyALGN0.8% of the fund+14%
- MicrosoftMSFT0.8% of the fund+65%
- Orthofix MedicalOFIX0.8% of the fund+21%
- AngiodynamicsANGO0.8% of the fund+18%
- VerastemVSTM0.7% of the fund+53%
Cut
Sold some of their stake.
- Neurocrine BiosciencesNBIX2.5% of the fund-26%
- Travere TherapeuticsTVTX2.5% of the fund-68%
- Agios PharmaceuticalsAGIO2.5% of the fund-12%
- PTC TherapeuticsPTCT2.4% of the fund-48%
- Dyne TherapeuticsDYN1.9% of the fund-3%
- ImmunovantIMVT1.9% of the fund-51%
- Ironwood PharmaceuticalsIRWD1.6% of the fund-7%
- Harmony Biosciences HoldingsHRMY1.6% of the fund-4%
- Uber TechnologiesUBER1.0% of the fund-4%
- AxogenAXGN1.0% of the fund-17%
- Disc MedicineIRON0.9% of the fund-14%
- Five9FIVN0.9% of the fund-4%
- HumanaHUM0.8% of the fund-49%
- Autolus TherapeuticsAUTL0.7% of the fund-5%
- MacrogenicsMGNX0.6% of the fund-17%
- Alto NeuroscienceANRO0.6% of the fund-5%
- Taiwan Semiconductor ManufacturingTSM0.6% of the fund-29%
- SentinelOneS0.6% of the fund-36%
- Intuitive SurgicalISRG0.5% of the fund-6%
- Nebius GroupNBIS0.5% of the fund-38%
- IntelINTC0.5% of the fund-42%
- Alibaba Group HldgBABA0.4% of the fund-18%
- Scholar Rock HoldingSRRK0.4% of the fund-18%
- PENN EntertainmentPENN0.4% of the fund-57%
- CrocsCROX0.4% of the fund-28%
Sold out
Sold their entire stake.
- Avanos MED-100%
- MedlineMDLN-100%
- Kalvista Pharmaceuticals-100%
- Energizer HoldingsENR-100%
- Meta PlatformsMETA-100%
- Esperion Therapeutics INC NE-100%
- Iqvia HoldingsIQV-100%
- Sangamo TherapeuticsSGMOQ-100%
- GE HealthCare TechnologiesGEHC-100%
- Tenax TherapeuticsTENX-100%
- Envista HoldingsNVST-100%
- IconICLR-100%
- DavitaDVA-100%
- Lineage Cell TherapeuticsLCTX-100%
- Amer SportsAS-100%
- Prothena Corp PublicPRTA-100%
- Keysight TechnologiesKEYS-100%
- MACOM Technology Solutions HoldingsMTSI-100%
- McDonald'sMCD-100%
- Corbus Pharmaceuticals HoldingsCRBP-100%
- Comfort Systems USAFIX-100%
- Advanced Micro DevicesAMD-100%
- CienaCIEN-100%
- Onto InnovationONTO-100%
- Victoria's SecretVSXY-100%
Holdings
- Sanofi SASNY
- Share
- 1.3%
- Value
- $45m
- Shares
- 1,064,000
+255%
- Immunocore HldgsIMCR
- Share
- 1.3%
- Value
- $45m
- Shares
- 1,428,000
+20%
- Autolus TherapeuticsAUTL
- Share
- 0.7%
- Value
- $24m
- Shares
- 15,000,000
-5%
- Grifols S AGRFS
- Share
- 0.6%
- Value
- $21m
- Shares
- 2,936,000
Held
- Alibaba Group HldgBABA
- Share
- 0.4%
- Value
- $16m
- Shares
- 168,000
-18%
- GSKGSK
- Share
- 0.4%
- Value
- $16m
- Shares
- 300,000
+27%
- Bicycle TherapeuticsBCYC
- Share
- 0.4%
- Value
- $14m
- Shares
- 3,398,000
Held
- NokiaNOK
- Share
- 0.3%
- Value
- $11m
- Shares
- 849,701
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Madrigal PharmaceuticalsMDGL | 4.3% | $155m | 288,000 | +9% |
| Supernus PharmaceuticalsSUPN | 3.4% | $123m | 2,646,201 | +40% |
| CytokineticsCYTK | 2.8% | $102m | 1,201,342 | +57% |
| IncyteINCY | 2.8% | $102m | 900,005 | +37% |
| Neurocrine BiosciencesNBIX | 2.5% | $90m | 535,838 | -26% |
| Travere TherapeuticsTVTX | 2.5% | $89m | 1,572,539 | -68% |
| Agios PharmaceuticalsAGIO | 2.5% | $89m | 2,400,000 | -12% |
| PTC TherapeuticsPTCT | 2.4% | $87m | 1,071,395 | -48% |
| UnitedHealth GroupUNH | 2.1% | $76m | 183,000 | +24% |
| FreshpetFRPT | 2.1% | $75m | 1,260,702 | +15% |
| Dyne TherapeuticsDYN | 1.9% | $69m | 3,087,226 | -3% |
| Amazon.comAMZN | 1.9% | $68m | 284,562 | +9% |
| ImmunovantIMVT | 1.9% | $67m | 1,736,000 | -51% |
| Rigel PharmaceuticalsRIGL | 1.8% | $65m | 1,672,000 | +31% |
| Thermo Fisher ScientificTMO | 1.7% | $61m | 122,480 | +34% |
| Ironwood PharmaceuticalsIRWD | 1.6% | $59m | 13,932,000 | -7% |
| Harmony Biosciences HoldingsHRMY | 1.6% | $57m | 1,564,000 | -4% |
| Regeneron PharmaceuticalsREGN | 1.5% | $56m | 89,809 | +149% |
| Nektar TherapeuticsNKTR | 1.4% | $51m | 724,000 | +25% |
| Mineralys TherapeuticsMLYS | 1.3% | $47m | 1,736,000 | +48% |
| Sanofi SASNY | 1.3% | $45m | 1,064,000 | +255% |
| Immunocore HldgsIMCR | 1.3% | $45m | 1,428,000 | +20% |
| AlphabetGOOGL | 1.3% | $45m | 126,494 | +7% |
| Solid BiosciencesSLDB | 1.2% | $43m | 4,278,000 | +34% |
| MongoDBMDB | 1.2% | $42m | 125,172 | +17% |
| Kura OncologyKURA | 1.1% | $40m | 3,678,000 | Held |
| Dentsply SironaXRAY | 1.1% | $39m | 3,672,000 | +22% |
| Uber TechnologiesUBER | 1.0% | $36m | 497,908 | -4% |
| AxogenAXGN | 1.0% | $36m | 775,000 | -17% |
| Disc MedicineIRON | 0.9% | $34m | 460,000 | -14% |
| GitlabGTLB | 0.9% | $33m | 1,074,141 | +4% |
| Five9FIVN | 0.9% | $33m | 1,536,000 | -4% |
| HubspotHUBS | 0.9% | $32m | 178,047 | +38% |
| Align TechnologyALGN | 0.8% | $30m | 180,286 | +14% |
| MicrosoftMSFT | 0.8% | $30m | 80,581 | +65% |
| Orthofix MedicalOFIX | 0.8% | $30m | 3,264,000 | +21% |
| HumanaHUM | 0.8% | $29m | 72,527 | -49% |
| AngiodynamicsANGO | 0.8% | $29m | 2,198,000 | +18% |
| WatersWAT | 0.8% | $28m | 75,004 | New |
| VerastemVSTM | 0.7% | $27m | 7,024,000 | +53% |
| 4D Molecular TherapeuticsFDMT | 0.7% | $27m | 2,000,000 | Held |
| Intellia TherapeuticsNTLA | 0.7% | $25m | 1,500,000 | +346% |
| Wynn ResortsWYNN | 0.7% | $25m | 261,065 | +50% |
| Treace Medical ConceptsTMCI | 0.7% | $25m | 6,364,000 | Held |
| Autolus TherapeuticsAUTL | 0.7% | $24m | 15,000,000 | -5% |
| ArvinasARVN | 0.6% | $23m | 2,796,000 | +41% |
| MacrogenicsMGNX | 0.6% | $23m | 5,006,752 | -17% |
| Alto NeuroscienceANRO | 0.6% | $23m | 864,000 | -5% |
| ToastTOST | 0.6% | $23m | 810,830 | +40% |
| UiPathPATH | 0.6% | $22m | 2,000,000 | +56% |
| Grifols S AGRFS | 0.6% | $21m | 2,936,000 | Held |
| Central Garden & PETCENTA | 0.6% | $21m | 536,000 | +12% |
| Taiwan Semiconductor ManufacturingTSM | 0.6% | $21m | 43,492 | -29% |
| SentinelOneS | 0.6% | $20m | 1,205,661 | -36% |
| LennarLEN | 0.6% | $20m | 221,444 | +25% |
| Intuitive SurgicalISRG | 0.5% | $19m | 48,804 | -6% |
| RHRH | 0.5% | $19m | 116,624 | +143% |
| Zeta Global HoldingsZETA | 0.5% | $19m | 965,273 | +8678% |
| WorkdayWDAY | 0.5% | $19m | 154,030 | +108% |
| Nebius GroupNBIS | 0.5% | $19m | 67,000 | -38% |
| IntelINTC | 0.5% | $18m | 129,011 | -42% |
| Alibaba Group HldgBABA | 0.4% | $16m | 168,000 | -18% |
| IlluminaILMN | 0.4% | $16m | 91,118 | New |
| Prestige Consumer HealthcarePBH | 0.4% | $16m | 336,000 | New |
| GSKGSK | 0.4% | $16m | 300,000 | +27% |
| Liberty MediaFWONK | 0.4% | $16m | 165,106 | New |
| Integer HoldingsITGR | 0.4% | $16m | 167,746 | New |
| Capri HoldingsCPRI | 0.4% | $16m | 836,000 | +27% |
| Xeris Biopharma HoldingsXERS | 0.4% | $16m | 1,958,702 | +3% |
| Scholar Rock HoldingSRRK | 0.4% | $15m | 278,000 | -18% |
| Live Nation EntertainmentLYV | 0.4% | $15m | 81,824 | New |
| Novo Nordisk A SNVO | 0.4% | $15m | 312,000 | New |
| Twist BioscienceTWST | 0.4% | $15m | 142,000 | New |
| AppLovinAPP | 0.4% | $15m | 28,228 | +16% |
| Bicycle TherapeuticsBCYC | 0.4% | $14m | 3,398,000 | Held |
| PENN EntertainmentPENN | 0.4% | $14m | 672,000 | -57% |
| Bristol-Myers SquibbBMY | 0.4% | $13m | 233,790 | +14% |
| BridgeBio Oncology TherapeuticsBBOT | 0.4% | $13m | 1,764,000 | +33% |
| CrocsCROX | 0.4% | $13m | 111,186 | -28% |
| Micron TechnologyMU | 0.4% | $13m | 11,567 | -50% |
| Bloom EnergyBE | 0.4% | $13m | 43,658 | -9% |
| Vera TherapeuticsVERA | 0.4% | $13m | 300,000 | Held |
| Take TWO Interactive SoftwareTTWO | 0.3% | $12m | 49,877 | New |
| Spyre TherapeuticsSYRE | 0.3% | $12m | 137,588 | +14% |
| Kymera TherapeuticsKYMR | 0.3% | $12m | 106,272 | +27% |
| Voyager TherapeuticsVYGR | 0.3% | $12m | 3,436,000 | Held |
| Marvell TechnologyMRVL | 0.3% | $12m | 39,978 | New |
| TeradyneTER | 0.3% | $12m | 24,540 | -44% |
| Generac HoldingsGNRC | 0.3% | $12m | 39,924 | -11% |
| RedditRDDT | 0.3% | $12m | 67,000 | -4% |
| Nuvation BioNUVB | 0.3% | $11m | 2,000,000 | +15% |
| Boston ScientificBSX | 0.3% | $11m | 265,201 | New |
| e.l.f. BeautyELF | 0.3% | $11m | 152,720 | +176% |
| NokiaNOK | 0.3% | $11m | 849,701 | New |
| NeuroPaceNPCE | 0.3% | $11m | 692,000 | Held |
| NetskopeNTSK | 0.3% | $11m | 1,000,000 | New |
| AirbnbABNB | 0.3% | $11m | 74,687 | +392% |
| FoxFOXA | 0.3% | $11m | 202,892 | New |
| Shake ShackSHAK | 0.3% | $10m | 183,118 | New |
| SemtechSMTC | 0.3% | $10m | 62,380 | Held |
Showing the largest 100 of 323.
Options (10)
- State STR Spdr S&P 500 ETF TSPY
- Type
- Put
- Value
- $2.4bn
- Contracts
- 3,200,000
- Ishares TRIWM
- Type
- Put
- Value
- $1.7bn
- Contracts
- 5,800,000
- CytokineticsCYTK
- Type
- Call
- Value
- $130m
- Contracts
- 1,530,000
- Agios PharmaceuticalsAGIO
- Type
- Call
- Value
- $104m
- Contracts
- 2,810,000
- PTC TherapeuticsPTCT
- Type
- Call
- Value
- $54m
- Contracts
- 660,000
- ImmunovantIMVT
- Type
- Call
- Value
- $46m
- Contracts
- 1,200,000
- Travere TherapeuticsTVTX
- Type
- Call
- Value
- $28m
- Contracts
- 500,000
- Mineralys TherapeuticsMLYS
- Type
- Call
- Value
- $28m
- Contracts
- 1,040,000
- SentinelOneS
- Type
- Call
- Value
- $27m
- Contracts
- 1,600,000
- GitlabGTLB
- Type
- Call
- Value
- $8m
- Contracts
- 270,000
| Company | Type | Value | Contracts |
|---|---|---|---|
| State STR Spdr S&P 500 ETF TSPY | Put | $2.4bn | 3,200,000 |
| Ishares TRIWM | Put | $1.7bn | 5,800,000 |
| CytokineticsCYTK | Call | $130m | 1,530,000 |
| Agios PharmaceuticalsAGIO | Call | $104m | 2,810,000 |
| PTC TherapeuticsPTCT | Call | $54m | 660,000 |
| ImmunovantIMVT | Call | $46m | 1,200,000 |
| Travere TherapeuticsTVTX | Call | $28m | 500,000 |
| Mineralys TherapeuticsMLYS | Call | $28m | 1,040,000 |
| SentinelOneS | Call | $27m | 1,600,000 |
| GitlabGTLB | Call | $8m | 270,000 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 37.0% since 30 June 2025.
Where the money is
Health care63.4%
Technology13.4%
Retail & consumer7.5%
Media & telecom3.5%
Industrials2.7%
Everyday goods2.6%
Financial services0.8%
Materials0.1%
Real estate0.1%
Energy0.1%
Utilities0.0%
Other5.7%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.